Global High-Priority Regulatory Events — June 26, 2026

26-06-2026

Ipca Laboratories Limited has approved the Scheme of Amalgamation of Krebs Biochemicals & Industries Ltd., its subsidiary, to achieve operational synergies, secure supply of critical fermentation-based APIs and drug intermediates, and enable R&D for new fermentation-based products. The transaction involves a share-swap ratio of 7 equity shares of Ipca for every 200 shares of Krebs, with no cash consideration, and will result in a marginal reduction in promoter shareholding from 44.72% to 44.66%. However, Krebs has been incurring continuous losses (total income of only Rs. 26 Crores versus Ipca's Rs. 7431 Crores, mostly from conversion charges) and the amalgamation aims to leverage Ipca's financial strength to turn around the business.

• · Krebs Biochemicals & Industries Ltd. has been continuously incurring losses and is unable to invest in R&D for new fermentation-based APIs.
• · The appointed date for the Scheme is 1st April 2026, effective upon receipt of all approvals.
• · The share exchange ratio is 7 equity shares of Re.1 each of Ipca for every 200 fully paid-up equity shares of Rs.10 each held in Krebs.
• · Equity and preference shares of Krebs held by Ipca shall be cancelled with no consideration issued.
• · Post-scheme promoter shareholding reduces marginally from 44.72% to 44.66% (a drop of only ~0.06 percentage points).
• · Public shareholding increases from 55.28% to 55.34%.
• · Krebs holds a manufacturing facility capable of producing fermentation-based APIs, a capability Ipca currently lacks.
• · Krebs supplies one fermentation-based API used in Ipca's largest-selling formulation, and only a handful of manufacturers exist globally for this API.

26-06-2026

The Board of Krebs Biochemicals & Industries Limited has approved a scheme of amalgamation with Ipca Laboratories Limited, with an appointed date of April 1, 2026. Under the scheme, Krebs (total income ₹26 Cr, loss-making) will be merged into Ipca (total income ₹7,431 Cr) in a share-for-share swap of 7 Ipca shares for every 200 Krebs shares, with no cash consideration. The merger aims to secure supply of a critical fermentation-based API and drug intermediates, while leveraging Ipca's financial strength to revive Krebs' R&D and manufacturing capabilities.

• · Krebs is continuously incurring losses and cannot fund R&D for new fermentation-based APIs.
• · Ipca does not have a fermentation-based API manufacturing capability, which Krebs possesses.
• · Krebs produces one fermentation-based API used in Ipca’s largest selling formulation, with only a handful of global manufacturers.
• · Krebs also produces few drug intermediates used in Ipca’s key APIs.
• · The transaction is a related party transaction and is being done at arm’s length.
• · The board meeting started at 11:30 a.m. and concluded at 1:00 p.m. on June 26, 2026.

26-06-2026

Kisan Mouldings Limited (KML) has approved a two-stage Scheme of Arrangement to amalgamate first its wholly owned subsidiary KML Tradelinks Private Limited (KTPL) into itself, and then amalgamate KML into Apollo Pipes Limited (APL). The scheme, effective from April 1, 2026, will see KML shareholders receive 4.96 equity shares of APL for every 100 shares held. The combined entity aims to achieve operational synergies, economies of scale, and enhanced market competitiveness, though the transaction will result in the delisting of KML and the cancellation of its equity shares.

• · The appointed date for the scheme is April 1, 2026.
• · KML's promoter shareholding pre-arrangement was 70.56% (8,42,87,623 shares); post-arrangement, all KML shares are cancelled.
• · APL's promoter shareholding post-arrangement will be 49.20% (2,27,80,000 shares) compared to 51.72% pre-arrangement, while public shareholding will increase from 47.99% to 50.52%.
• · The share exchange ratio is 4.96 equity shares of APL (face value ₹10 each) for every 100 equity shares of KML (face value ₹10 each).
• · KTPL has zero turnover and negligible net worth (₹0.02 Cr), making its amalgamation a purely structural step.
• · The scheme is subject to approvals from shareholders, creditors, stock exchanges, SEBI, NCLT, and other regulatory authorities.

26-06-2026

Apollo Pipes Limited (APL) announced a Scheme of Arrangement to amalgamate its wholly-owned step-down subsidiary KML Tradelinks (KTPL) into Kisan Mouldings (KML), and then KML into APL. APL will issue 4.96 equity shares for every 100 shares held in KML. The scheme aims to achieve operational synergies, cost reduction, and a stronger market presence, but comes with significant regulatory approvals and potential dilution for existing APL shareholders.

• · Appointed date for the scheme: April 1, 2026
• · The first step amalgamation (KTPL into KML) involves no issuance of shares as KTPL is a wholly owned subsidiary of KML.
• · The second step amalgamation (KML into APL) share exchange ratio: 4.96 APL shares for every 100 KML shares (face value ₹10 each).
• · Fairness opinion on share exchange ratio provided by Corporate Professionals Capital Private Limited (SEBI registered Category-I Merchant Banker).
• · Registered Valuer for valuation report: Axiology Valuetech Private Limited (IBBI registered).
• · The scheme requires approvals from shareholders, creditors, BSE, NSE, SEBI, and NCLT.
• · KML's promoter holding in APL post-arrangement becomes public holding, leading to promoter dilution from 51.72% to 49.20% in APL.
• · KML shareholders receive APL shares, thus the public shareholding in APL increases from 47.99% to 50.52%.

26-06-2026

NTPC Limited has incorporated a new wholly owned subsidiary, NTPC (Mauritius) Energy Limited, in Mauritius on June 26, 2026, to develop a Floating Solar Photovoltaic (FSPV) project with Battery Energy Storage System (BESS) and pursue other power sector businesses in Mauritius. The subsidiary is capitalized at MUR 1,000,000 (approx. INR 19,80,000) and is a newly incorporated entity with no current turnover. This is a small initial investment for a project development vehicle, with no financial returns expected in the near term.

• · The subsidiary was incorporated pursuant to the disclosure made on 23rd December 2025.
• · The entity is a wholly owned subsidiary of NTPC Limited.
• · No governmental or regulatory approvals have been mentioned as required; the filing lists Ministry of Power, DIPAM, and Registrar of Companies, Mauritius as likely approval bodies.
• · The consideration for acquisition is subscribed in cash.

26-06-2026

Omkar Overseas Ltd has filed a notice regarding a meeting of equity shareholders convened by the NCLT, Ahmedabad Bench, to be held on July 27, 2026 via VC/OAVM. The filing includes newspaper advertisements published on June 26, 2026. No financial figures or performance metrics are disclosed in this filing.

• · NCLT order dated June 4, 2026 directed the meeting of equity shareholders.
• · Meeting scheduled for July 27, 2026 via Video Conferencing / Other Audio-Visual Means.
• · Newspaper advertisements published in Financial Express (English and Gujarati editions) on June 26, 2026.

26-06-2026

The 9th Committee of Creditors (CoC) meeting of Dhruv Wellness Limited, held on January 8, 2026, approved the resolution plan submitted by M/s. Barouliya Fragrancia Private Limited along with Mr. Rajesh Barouliya and Mr. Vineet Mittal, with a total plan value of ₹5,55,00,000. The meeting achieved a quorum with 98.55% voting share present. However, two resolution applicants withdrew their plans, and the company remains under Corporate Insolvency Resolution Process (CIRP) with pending legal applications for extension of the CIRP period.

• · The meeting was originally scheduled at 12:30 PM but was preponed to 11:00 AM at the request of a financial creditor.
• · Two resolution applicants (MG369 Finventure with Value added Fashions Private Limited and Prafull Chedda Enterprise Private Limited) withdrew their plans before the meeting.
• · Prafull Chedda alleged that the CIR process was not in line with IBC rules, but the CoC members supported the RP, stating the process was transparent.
• · The approved resolution plan by Barouliya Fragrancia Private Limited proposes payment within 30 days after approval of the resolution plan.
• · Natesh Consultancy Private Limited & Sarvottam Décor Private Limited submitted only a one-page revised summary instead of a complete revised plan.
• · Thanvir Bro’s Private Limited did not submit a revised financial offer; their last submitted plan was treated as final.
• · The RP appointed Mr. Divyansh Goyal for compliance review of resolution plans at the lowest quotation of ₹35,000 per plan.
• · The meeting also discussed the course of action in case of liquidation of the corporate debtor.
• · Suspended directors were not present at the meeting.
• · The GST Department (operational creditor for government dues) and Kotak Mahindra Bank Ltd (unsecured financial creditor) were absent from the meeting.

26-06-2026

Tilaknagar Industries Limited (TI) has approved a further investment of ₹2 Crore in Round the Cocktails Private Limited (Bartisans) by subscribing to 1,569 Compulsory Convertible Preference Shares at ₹12,752 per CCPS. Post investment, TI's stake in Bartisans will increase to 41.45%. Bartisans, a ready-to-pour cocktail mixer company, reported flat turnover of ₹3.5 Cr in FY26 (same as FY24) and net worth of ₹1.0 Cr, indicating stagnant top-line performance despite TI's continued backing.

• · Bartisans was incorporated on 19-Aug-2021.
• · The investment is a cash consideration transaction.
• · Completion of the acquisition is expected on or before 31st August 2026.
• · The transaction is at arm's length and does not involve related parties.
• · Bartisans' net worth as of March 31, 2026 is only ₹1.0 Crore, indicating a thin equity base.
• · No governmental or regulatory approvals are required for the acquisition.

26-06-2026

Gujarat Fluorochemicals Limited (GFCL) has incorporated a wholly-owned subsidiary, GFCL Semiconductor and Advanced Materials Limited, on June 26, 2026, in India. The subsidiary will operate in specialty chemicals and semiconductor devices, including integrated circuits. The company subscribed to equity shares at a cost of ₹1 Lakh, representing 100% shareholding.

• · The subsidiary is incorporated in India.
• · The subsidiary's business includes designing, developing, manufacturing, and dealing in specialty chemicals, semiconductor devices, integrated circuits, electronic components, software, and related technologies.
• · No governmental or regulatory approvals were required for the incorporation.
• · The consideration is in cash.

26-06-2026

Powerica Ltd announced the incorporation of a wholly owned subsidiary, Windfusion Renewable Private Limited, on June 26, 2026, with the approval of the Ministry of Corporate Affairs. The subsidiary is focused on renewable energy projects including wind, solar, and hybrid power. Powerica subscribed to 100% of the subsidiary's paid-up share capital (250,000 equity shares at ₹10 each) for a total cash consideration of ₹2,500,000.

• · The subsidiary is incorporated in India under the Companies Act.
• · The subsidiary's main objects include setting up and developing wind, solar, wind-solar hybrid, and other renewable power projects.
• · No governmental or regulatory approvals were required for the incorporation beyond the Ministry of Corporate Affairs approval.
• · The consideration is in cash and the listed entity holds 100% control over the WOS.

26-06-2026

Sunteck Realty Limited has incorporated a wholly-owned subsidiary, Eminara Buildcon Private Limited (EBPL), on June 26, 2026, for real estate activities. The company subscribed to 10,000 equity shares of ₹10 each for a total cash consideration of ₹1,00,000, resulting in 100% ownership. This is a routine corporate structuring move with no related-party or regulatory approval implications.

• · The subsidiary is incorporated in India and classified under the real estate industry.
• · No governmental or regulatory approvals were required for the incorporation.
• · The transaction is not a related-party transaction, and no promoter/group entities have an interest in EBPL.

26-06-2026

Bharatam Ventures Limited (formerly Pet Plastics Ltd.) completed the acquisition of a 99.9987% equity stake in Penganga Sakhar Karkhana Private Limited for a cash consideration of ₹1,79,99,760 (₹1.79 Crore). The target company is engaged in sugar manufacturing and allied agro-processing, with turnover growing from ₹1,404 Lakh in FY24 to ₹8,352.89 Lakh in FY26. The acquisition is a strategic diversification into the sugar sector, but no financial details of the acquirer or funding sources were disclosed.

• · The acquisition was completed on June 26, 2026, following a disclosure on May 28, 2026.
• · The target company's turnover grew from ₹1,404 Lakh in FY24 to ₹8,352.89 Lakh in FY26, showing rapid growth.
• · The acquisition is not a related party transaction and was done on an arm's length basis.
• · No governmental or regulatory approvals are pending post-completion.

26-06-2026

TIAN RUIXIANG HOLDINGS LTD (TIRX) has been notified by Nasdaq that its Class A Ordinary Shares will be delisted effective July 6, 2026, following a final determination that the company no longer meets listing requirements under Listing Rules 5550(a)(2) and 5810(c)(3)(A)(iii). The company's shares were suspended on March 5, 2026, and an appeal to the Listing Qualifications Hearings Panel was unsuccessful, with the delisting decision becoming final on April 27, 2026.

• · Delisting effective at the opening of the trading session on July 6, 2026.
• · Nasdaq Staff determination on January 20, 2026 that the company no longer qualified under Listing Rule 5550(a)(2).
• · Company appealed on January 22, 2026; hearing held on February 17, 2026.
• · Additional Staff determination on March 3, 2026 under Listing Rule 5810(c)(3)(A)(iii).
• · Shares suspended on March 5, 2026.
• · Panel decision issued March 12, 2026; shares remained suspended.
• · Staff determination to delist became final on April 27, 2026.

26-06-2026

Glittek Granites Ltd. announced the reclassification of former promoters (Sellers) to public shareholders following a change in control. The Acquirers, led by Maheshkumar Jatashankar Thanki and others, acquired 62.99% equity from Sellers via a share purchase agreement and completed an open offer for an additional 26%. The new promoter group now holds 70.59% of the company effective June 26, 2026.

• · Share purchase agreement dated January 6, 2025
• · Open offer post-offer advertisement submitted on June 16, 2026
• · Board meeting outcome on June 25, 2026 confirmed change in management and control
• · Sellers reclassified to public: Ashoke Agarwal (2.57%), Manjula Agarwal (5.77%), Tushar Agarwal (4.64%), Ashoke Agarwal & Others HUF (0.03%), Kosen Ventures (49.98%)
• · New promoter group includes Rawmin Mining And Industries Private Limited (no shares held directly)

26-06-2026

Petrobras - Petroleo Brasileiro SA has filed a Form 25-NSE with the SEC, notifying the delisting and deregistration of its 7.375% Global Notes due January 17, 2027, from the New York Stock Exchange. The delisting is effective as of July 7, 2026, following the full redemption, maturity, or retirement of the entire class of these securities on June 26, 2026, with sufficient funds deposited for payment. Trading in these securities was suspended on June 26, 2026.

• · The delisting is pursuant to Rule 12d2-2(a)(1) under the Securities Exchange Act of 1934.
• · The security was suspended from trading on June 26, 2026.
• · The delisting becomes effective at the opening of business on July 7, 2026.
• · The filing was made by the New York Stock Exchange LLC, not by Petrobras directly.

26-06-2026

Petrobras Global Finance B.V. is delisting its 7.375% Global Notes due January 17, 2027 from the New York Stock Exchange, effective July 7, 2026. The securities were called for redemption/maturity on June 26, 2026, with sufficient funds deposited for payment, and trading was suspended on that date.

• · Delisting effective date: July 7, 2026
• · Redemption/maturity date: June 26, 2026
• · Trading suspended on June 26, 2026
• · Rule 12d2-2(a)(1) provision cited

26-06-2026

Charlton Aria Acquisition Corp (CHARU) announced that Nasdaq confirmed the company has regained compliance with Listing Rule 5250(c)(1) following the filing of its overdue Form 10-K for FY2025 and Form 10-Q for Q1 2026. The Nasdaq Listing Qualifications Department closed the matter on June 23, 2026, after the company remedied its filing delinquency. No financial figures or business transactions were disclosed in this filing.

26-06-2026

Israel Acquisitions Corp (IAC) terminated its business combination agreement with Gadfin Ltd. on June 22, 2026, along with the related Sponsor Support Agreement. The termination follows a series of amendments to the original January 2025 agreement, and no new transaction has been announced.

• · The business combination agreement was originally entered into on January 26, 2025, and was amended multiple times before termination.
• · The agreement contemplated a structure where IAC and Gadfin would become wholly owned subsidiaries of a newly formed Israeli holding company, Gadfin Regev Holdings Ltd.
• · The Sponsor Support Agreement included provisions for forfeiture of up to 1,429,000 Sponsor Shares if the Sponsor's holding exceeded 30% of NewPubco's shares post-closing.
• · No reason for the termination was disclosed in the filing.

26-06-2026

Cboe BZX Exchange, Inc. filed a Form 25-NSE with the SEC on June 26, 2026, to delist and deregister four ETFs issued by Investment Managers Series Trust II: Tradr 2X Short CLSK Daily ETF (CLSZ), Tradr 2X Long HL Daily ETF (HLXX), Tradr 1X Short Innovation 100 Monthly ETF (SMQ), and Tradr 2X Long SRPT Daily ETF (SRPU). The delisting is effective at the opening of business on July 6, 2026, following the redemption or maturity of the entire class of securities on June 18, 2026, and a trading suspension that began on June 12, 2026.

• · The delisting is pursuant to Rule 12d2-2(a)(2) under the Securities Exchange Act of 1934.
• · The securities were redeemed or paid at maturity or retirement on June 18, 2026.
• · Trading was suspended on June 12, 2026.
• · The delisting becomes effective at the opening of business on July 6, 2026.

26-06-2026

Nasdaq Stock Market LLC filed a Form 25-NSE with the SEC on June 26, 2026, to delist the warrants of NEXTNAV INC. (NXNVW) from the Nasdaq exchange. The delisting is effective as of the same date, under SEC Rule 17 CFR 240.12d2-2(a)(1). This action removes the warrants from trading on the national securities exchange.

• · The delisting is effective on June 26, 2026.
• · The filing is made under SEC Rule 17 CFR 240.12d2-2(a)(1).
• · The company was formerly known as Spartacus Acquisition Shelf Corp. until June 3, 2021.
• · The warrants were listed under the symbol NXNVW.

26-06-2026

Willow Lane Acquisition Corp. II appointed Joseph Samuels as a Class I director on June 22, 2026. Mr. Samuels, founder and CEO of Islet Management, LP, brings extensive experience from Och-Ziff Capital Management, Pequot, and Merrill Lynch. The appointment was accompanied by standard joinder agreements consistent with the company's IPO terms.

• · Joseph Samuels, age 51, was appointed as a Class I director effective June 22, 2026.
• · Mr. Samuels has served as founder and CEO of Islet Management, LP since January 2018.
• · Previously, he was a Partner at Och-Ziff Capital Management (Dec 2003 – Jul 2016), serving as Co-Head of U.S. Equity Business and Head of Trading.
• · No family relationships or reportable transactions exist between Mr. Samuels and the company.
• · The company entered into a joinder to the letter agreement and indemnity agreement with Mr. Samuels on terms consistent with those filed on February 19, 2026.

26-06-2026

Upexi, Inc. received a Nasdaq delisting notice on June 24, 2026 for failing to obtain shareholder approval on two convertible note issuances totaling approximately $187 million, which could convert into 20% or more of pre-transaction shares. The company has until August 10, 2026 to submit a compliance plan; however, there is no assurance the plan will be accepted. Separately, on June 26, 2026, the company announced its addition to the Russell Microcap® Index, effective June 29, 2026.

• · The two transactions involved SOL: $151.2M convertible at $4.25/share on July 9, 2025, and $36M convertible at $2.39/share on January 9, 2026.
• · The notice has no immediate effect on the listing or trading of the common stock on the Nasdaq Capital Market.
• · If Nasdaq does not accept the compliance plan, the company may appeal to a Hearings Panel.

26-06-2026

Crescent Private Credit Income Corp. filed a final amendment to its tender offer statement, reporting that zero shares were tendered in its offer to purchase up to 1,023,865 shares at net asset value per share as of May 31, 2026. The offer expired on June 24, 2026, and the company will not purchase any shares. This indicates no shareholder interest in the tender offer at the offered price.

• · The tender offer expired at 11:59 p.m., Eastern Time, on June 24, 2026.
• · The offer was originally filed on May 26, 2026.
• · The purchase price was set at the net asset value per share of the applicable class as of May 31, 2026.
• · No shares were tendered, so no purchase will occur.

26-06-2026

Stratus Properties Inc. completed the sale of the retail component of Jones Crossing in College Station, Texas for $46.5 million in cash, generating pre-tax net cash proceeds of approximately $21.7 million after selling costs and loan repayment. This is the company's fourth recent sale of a stabilized retail project as part of its plan of complete liquidation and dissolution, approved by stockholders on June 1, 2026. While the sale marks continued progress in monetizing assets, Stratus retains the 21-acre multi-family component of Jones Crossing, and the ultimate amount and timing of distributions to stockholders remain uncertain.

• · Stockholders approved the Plan of Liquidation at the 2026 annual meeting on June 1, 2026, and the Board had previously approved it.
• · The sale includes 154,092 sq ft of retail space, two retail pad sites subject to ground leases, and approximately 22 undeveloped commercial acres.
• · Stratus retains the 21-acre multi-family component of Jones Crossing, including the ground lease underlying the multi-family property.
• · The company has a development portfolio of approximately 1,500 acres of commercial and residential projects under development or undeveloped land.
• · Risks include unexpected transaction costs, delayed closings, liquidation costs, and the ability to market and sell all assets.

26-06-2026

International Media Acquisition Corp. (IMAQ) deposited $2,000 into its trust account to extend the deadline to complete a business combination by one month, from July 2, 2026 to August 2, 2026. This is the 19th extension out of 24 available, highlighting the company's ongoing challenges in consummating a deal and its continued reliance on extensions to preserve the SPAC structure.

• · The trust account extension letter is dated June 26, 2026.
• · The original Investment Management Trust Agreement was dated July 28, 2021, and has been amended multiple times (July 26, 2022; January 27, 2023; July 31, 2023; January 2, 2024; December 31, 2024).
• · The extension is authorized under Section 1(j) of the Trust Agreement.
• · The company's principal executive offices are located at 1221 Brickell Avenue, Miami, FL 33131.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.

26-06-2026

Coeptis Therapeutics Holdings, Inc. filed an S-1 registration statement on June 26, 2026, registering up to 100,000 shares of Common Stock (0.19% of outstanding) for resale by a selling securityholder following its April 2026 business combination with Z Squared Inc. The company transitioned from biopharmaceuticals to digital asset mining, acquiring a fleet of 9,800 ASIC miners valued at $660.3M. However, the company faces substantial going concern risk with an accumulated deficit of $113.9M as of March 31, 2026, and its primary cryptocurrency, Dogecoin, was trading at $0.085 per DOGE as of June 8, 2026—below its estimated breakeven price of $0.13–$0.15 per DOGE, threatening operational viability.

• · Lock-up restrictions on BSG-distributed shares: no sales unless VWAP > $16.00 over 10 trading days; monthly cap of 1/18th of shares; sales ≤5% of 10-day average daily volume; no short sales; restrictions terminate if closing price > $35.00 for two consecutive days.
• · Hosting power cost under MSA with Minting Dome: $0.088 per kWh.
• · Breakeven DOGE price: ~$0.13 per DOGE (with LTC credit) and ~$0.15 per DOGE on a DOGE-only basis.
• · OpCo was incorporated in December 2022 and had not commenced principal operations or generated revenue prior to the Business Combination.
• · The fleet consists predominantly of overclocked L7 units, not L9 units assumed in the $660.3M valuation.
• · GEAR Therapeutics retained; Coeptis issued 1,000,000 shares to CHI and granted CHI an option to acquire GEAR at fair market value, exercisable from October 24, 2026 for 24 months.
• · Common stock trades on Nasdaq Global Market under symbol 'ZSQR'.

26-06-2026

Hawthorn Bancshares, Inc. (HWBK) filed an S-4 registration statement with the SEC on June 26, 2026, in connection with its merger with FBI (First Bancshares, Inc.). The pro forma combined entity would have total assets of $2.23B and total deposits of $1.86B as of March 31, 2026. Pro forma net income for FY2025 is $25.8M (basic EPS $3.52), up from HBI standalone net income of $23.8M (basic EPS $3.44), reflecting accretion from the transaction. However, the merger is expected to incur $3.8M in estimated merger costs (net of $0.8M taxes), and the pro forma adjustments include $2.2M in additional non-interest expense for FY2025, partially offsetting the benefits.

• · Pro forma total assets of $2.23B as of March 31, 2026, up from HBI standalone $1.86B and FBI $383.8M.
• · Pro forma total deposits of $1.86B as of March 31, 2026, with $490.4M non-interest bearing and $1.37B interest-bearing.
• · Pro forma net loans of $1.71B as of March 31, 2026, with allowance for credit losses of $22.8M.
• · Pro forma goodwill of $16.1M and core deposit intangible of $7.6M recorded as of March 31, 2026.
• · Pro forma net interest income for FY2025 was $79.7M, up from HBI standalone $65.9M and FBI $12.8M.
• · Pro forma non-interest expense for FY2025 was $63.5M, including $2.2M in acquisition-related adjustments.
• · Estimated merger costs of $3.8M (net of $0.8M taxes) are excluded from pro forma financials and will be recognized over time.
• · Pro forma basic EPS for FY2025 was $3.52, compared to HBI standalone $3.44, representing ~2.3% accretion.
• · Pro forma basic EPS for Q1 2026 was $0.88, compared to HBI standalone $0.83, representing ~6.0% accretion.

26-06-2026

Texas Ventures Acquisition IV Corp completed its IPO of 17.25 million units at $10.00 per unit on June 22, 2026, generating gross proceeds of $172.5 million, along with a $6.1 million private placement of warrants. Approximately $173.4 million was deposited into a trust account; however, the company has an accumulated deficit of $5.6 million and the auditor has raised a going concern warning due to expected significant expenses in identifying and consummating a business combination.

• · Transaction costs totaled $10,735,483 (cash underwriting fee $3.45M, deferred fee $6.9M, other costs $385,483).
• · The company has no operations and expects to incur significant expenses related to identifying and evaluating business combination candidates.
• · Auditor stated no critical audit matters were identified.
• · Company is required to complete a business combination with a target having a fair market value equal to at least 80% of trust assets.
• · Company must acquire at least 50% voting control or a controlling interest in the target.

26-06-2026

Matinas BioPharma received a second NYSE American non-compliance notice on June 24, 2026, for failing Section 1003(a)(ii) (stockholders' equity < $4.0M with recent losses), adding to a prior Section 1003(a)(iii) violation. The company's stockholders' equity was $3,022,000 as of March 31, 2026, and it has reported net losses in five of its most recent fiscal years. However, the NYSE American accepted the company's compliance plan and granted a plan period through October 2, 2027, so the stock continues trading normally under MTNB for now.

• · The company is not eligible for the Section 1003(a) exemption for companies with market capitalization exceeding $50 million.
• · The compliance plan was accepted by NYSE American on June 24, 2026, with a plan period through October 2, 2027.
• · If the company fails to regain compliance or make progress consistent with the plan, NYSE American staff may initiate delisting proceedings.
• · The June Notice has no immediate impact on the listing or trading of MTNB common stock.

26-06-2026

Hall Chadwick Acquisition Corp. (HCACU) appointed Ms. Stephanie Wei-Ni Wen, age 48, as a director effective June 24, 2026. Ms. Wen has over 15 years of experience in cross-border transactions and corporate governance, most recently serving as General Counsel and Company Secretary of ASX-listed Kingsgate Consolidated Limited. The filing does not provide any financial metrics or period-over-period comparisons, nor does it mention performance indicators.

• · Ms. Wen holds Bachelor of Laws and Bachelor of Commerce (Accounting) from University of New South Wales and a Master of International Affairs from Columbia University.
• · She previously served as a non-executive director of ASX-listed Quantum Health Group Limited from September 2021 to April 2022.
• · Ms. Wen is expected to enter into the Company's standard form of indemnification agreement for directors and officers.

27-06-2026

Persistent Systems has established a German subsidiary (Galaxy Germany Holding SE) and through it agreed to acquire a 21% stake in Nagarro SE from its largest shareholder at €81.00 per share, with a subsequent voluntary public takeover offer for the remaining shares. The combined Persistent–Nagarro entity would create a ~$2.9 billion AI-led engineering powerhouse with 46,000+ employees across 40+ countries. However, the deal is subject to multiple regulatory approvals and shareholder votes, with settlement expected only in Q4 CY2026/Q1 CY2027, and Nagarro's revenue growth has been modest (CY25: €999.3M vs CY24: €972.0M, a ~2.8% increase).

• · Nagarro has ~18,500 employees across 40+ countries, with ~13,500 in India, ~3,000 in Europe, ~500 in US, and ~1,500 in RoW.
• · The combined entity is projected to have strong vertical presence: BFSI, HLS, TMT ($500M+ each), Industrials ($400M+), Consumer ($300M+).
• · Nagarro's revenue growth has been modest: CY25 €999.3M (+2.8% YoY), CY24 €972.0M (+6.6% YoY).
• · The acquisition of the 21% stake is subject to regulatory approvals; the full takeover offer requires shareholder approval and multiple regulatory clearances.
• · Settlement of the Voluntary Public Takeover Offer is expected in Q4 CY2026 / Q1 CY2027.

26-06-2026

Outlook Therapeutics, Inc. (OTLK) announced it received a letter from Nasdaq on June 26, 2026, confirming it has regained compliance with the minimum bid price requirement (closing bid price at or above $1.00 for ten consecutive business days) after previously facing delisting. The matter is now closed, and the company's common stock will continue trading on the Nasdaq Capital Market.

• · The company initially received a delisting notice on February 18, 2026 for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days under Nasdaq Listing Rule 5550(a)(2).
• · Compliance was regained based on a closing bid price of $1.00 or greater for the ten consecutive business days ending June 25, 2026.
• · The compliance confirmation letter was received on June 26, 2026.

26-06-2026

Grosvenor Registered Multi-Strategy Master Fund, LLC announced an issuer tender offer to repurchase up to $32,300,000 of its limited liability company interests at net asset value as of September 30, 2026. The offer expires on July 27, 2026, unless extended. As of June 1, 2026, outstanding interests totaled approximately $136.7 million, and the adviser and its affiliates own only 0.01% of outstanding interests, with no directors or officers holding any.

• · The tender offer is an issuer self-tender under Rule 13e-4; the Fund is a closed-end diversified management investment company registered under the 1940 Act.
• · Interests are not traded in any market; transfers are strictly limited by the LLC Agreement.
• · The Board expects the Adviser to recommend quarterly repurchase offers (four times per year).
• · If the Fund does not repurchase any tendered Interests at least once in any 24-month period, the LLC Agreement requires a shareholder meeting to consider dissolution.
• · The previous tender offer expired on April 27, 2026.
• · No executive officer, director, or affiliate plans to tender in this offer.
• · No solicitation or recommendation persons have been retained or compensated in connection with the offer.

26-06-2026

Grosvenor Registered Multi-Strategy Fund (TI 2), LLC announced an issuer tender offer to repurchase up to $17,500,000 of its Shares at net asset value as of September 30, 2026. The offer expires on July 27, 2026, and is part of the Fund's regular quarterly repurchase program. As of June 1, 2026, outstanding Shares were approximately $72,306,590, and the Adviser and its affiliates own only 0.05% of the Fund.

• · The tender offer is an issuer tender offer subject to Rule 13e-4.
• · The Fund is a closed-end, diversified, management investment company registered under the 1940 Act.
• · Shares are not traded on any market and transfers are strictly limited by the LLC Agreement.
• · The Adviser expects to recommend quarterly repurchases effective as of the last business day of each calendar quarter.
• · If the Fund does not repurchase any Shares at least once every 24 months, the Board must call a meeting to consider dissolution.
• · No executive officer, director, or affiliate plans to tender Shares in this offer.
• · The previous tender offer expired on April 27, 2026.
• · Investors may withdraw tenders at any time before the Expiration Date, and after August 21, 2026 if not yet accepted.

26-06-2026

Grosvenor Registered Multi-Strategy Fund (TI 1), LLC announced an issuer tender offer to repurchase up to $14.8 million of its Shares at net asset value as of September 30, 2026. The offer expires on July 27, 2026, unless extended. As of June 1, 2026, outstanding Shares were approximately $64.4 million, and the Adviser and affiliates own only 0.29% of outstanding Shares, with no executive officers or directors holding any Shares.

• · The tender offer is an issuer tender offer subject to Rule 13e-4, not a third-party offer.
• · Shares are not traded on any market; transfers are strictly limited by the LLC Agreement.
• · The Board has discretion to extend the offer; the Valuation Date will be at least 65 days after the actual expiration date.
• · Investors may withdraw tenders at any time before the Expiration Date, and after August 21, 2026 if not yet accepted.
• · The Adviser expects to recommend quarterly repurchase opportunities (four times per year).
• · If the Fund does not repurchase any Shares at least once every 24 months, the Board must call a meeting to consider dissolution.
• · No executive officer, director, or affiliate plans to tender Shares in this offer.
• · The Fund’s previous tender offer expired on April 27, 2026.

26-06-2026

Hedge Fund Guided Portfolio Solution announced an issuer tender offer to repurchase up to $33,700,000 of its shares at net asset value as of September 30, 2026. The offer expires on July 27, 2026, unless extended. The fund had approximately $139,811,407 in outstanding shares as of June 1, 2026, and the repurchase represents about 24.1% of outstanding shares. The adviser and affiliates own only 0.10% of shares, and no executive officers or trustees plan to tender.

• · The Fund is a closed-end, non-diversified, management investment company registered under the 1940 Act, organized as a Delaware statutory trust.
• · Shares are not traded in any market and transfers are strictly limited by the Fund's Declaration of Trust.
• · The Adviser expects to recommend quarterly repurchase offers (four times per year) effective as of the last business day of each calendar quarter.
• · The previous tender offer had an expiration date of April 27, 2026.
• · No persons have been retained to make solicitations or recommendations in connection with the offer.
• · Investors may withdraw tenders at any time before the Expiration Date, and after August 21, 2026 if the Fund has not yet accepted the tender.

26-06-2026

Evanston Multi-Alpha Fund announced a tender offer to repurchase up to $14.5M (15% of net assets) of its Class A and Class I shares, with key dates including a July 28, 2026 notice deadline and September 30, 2026 valuation date. Concurrently, the Board approved a transition to a new investment adviser (XA Investments LLC) and a conversion to an interval fund, both subject to shareholder vote at an August 13, 2026 special meeting. While the tender offer provides immediate liquidity, the fund's net asset value per share has declined from $9.4956 (aggregate) to $8.5548 (Class A) and $9.5287 (Class I) as of April 30, 2026, and the proposed changes face shareholder approval risk.

• · The tender offer expires on July 28, 2026 (Notice Date), with withdrawal rights until the same date (Expiration Date).
• · Payment for repurchased shares is generally made within ~35 days after the Repurchase Valuation Date (September 30, 2026).
• · Shareholders tendering within the first year of purchase are subject to a 3.00% Early Repurchase Charge.
• · The Fund's net asset value per share as of April 30, 2026 was $8.5548 (Class A) and $9.5287 (Class I), with an aggregate NAV of $9.4956.
• · The Transition and Proposed Conversion are subject to shareholder approval at a special meeting on August 13, 2026.
• · If approved, the interval fund conversion will occur within 15 months after the shareholder vote.
• · The Fund has the right to cancel, amend, or postpone the tender offer at any time before the Expiration Date.

26-06-2026

Prospect Floating Rate & Alternative Income Fund, Inc. filed a tender offer to repurchase shares using cash retained from its distribution reinvestment plan (DRIP) during the quarter ended March 31, 2026. The offer price will be the NAV per share as of July 31, 2026, with an illustrative NAV of $3.83 per share as of April 30, 2026. As of June 26, 2026, there were 9,527,417 Class A and Class I shares outstanding and 756 holders of record, while no Class S or Class D shares were outstanding.

• · The offer is for cash at a price equal to NAV per share as of July 31, 2026.
• · The Company is externally managed, non-diversified, closed-end management investment company regulated as a BDC under the 1940 Act.
• · Shares are not traded on an established trading market.
• · No Class S or Class D shares were outstanding as of June 26, 2026.
• · The Company does not have any present plans for extraordinary transactions, changes in dividend policy, board changes, or delisting.

26-06-2026

ProAssurance Corporation filed an 8-K on June 26, 2026, indicating a material agreement termination and changes in control, directors, and corporate governance. The filing includes a Second Amended and Restated Certificate of Incorporation that reduces authorized shares to 2,000 common shares at $0.0001 par value, suggesting a significant corporate restructuring or going-private transaction. The document also provides for director liability limitation and indemnification provisions.

• · The corporation is incorporated in Delaware with registered office at 1209 Orange Street, Wilmington, New Castle County 19801.
• · The corporation has perpetual existence.
• · Management of business and conduct of affairs is vested in the board of directors, which is authorized to make, adopt, alter, amend or repeal By-laws.
• · Stockholder meetings may be held within or without Delaware as By-laws provide.
• · Directors have no personal liability for monetary damages for breach of fiduciary duty except as required by law.
• · The corporation shall indemnify directors and officers to the fullest extent permitted by DGCL, including for actions by or in the right of the corporation.
• · Indemnification is not exclusive of other rights, and amendments to indemnification provisions do not apply to acts or omissions occurring prior to such amendments.

26-06-2026

AB Private Lending Fund announced an issuer tender offer to repurchase up to 338,368 of its Class I, Class D, and Class S shares, representing approximately 5% of outstanding shares as of March 31, 2026. The purchase price will be the net asset value as of June 30, 2026, with payment expected by August 6, 2026. The offer expires on July 30, 2026, and no officers, trustees, or affiliates (except certain major shareholders) intend to tender shares.

• · Shares are not traded in any market.
• · The Adviser expects to recommend quarterly tender offers, but the Fund is not required to conduct them.
• · EFS (65.0% owner) is subject to a lock-up agreement until the fifth anniversary of the Fund's BDC election, with quarterly repurchase limits of 1.67% of total shares outstanding unless overall repurchase requests are below 5%.
• · None of the officers, trustees, or affiliates (except possibly some shareholders deemed affiliates due to ownership) intend to tender shares in this offer.
• · The Fund has not borrowed funds for the repurchase but may decide to do so depending on tender volume and market conditions.
• · Audited annual financial statements as of December 31, 2025, and unaudited statements as of March 31, 2026, are incorporated by reference.

26-06-2026

TLGY Acquisition Corporation filed Form 15 to terminate its registration under Section 12(g) of the Securities Exchange Act of 1934, effective June 26, 2026, following the consummation of its business combination with StablecoinX Inc. on June 25, 2026. As a result of the merger, TLGY became a wholly owned subsidiary of StablecoinX, and the number of holders of record of its securities dropped to 1. The deregistration relieves TLGY of its duty to file periodic reports with the SEC, though StablecoinX's reporting obligations remain unaffected.

• · The business combination was previously announced and consummated on June 25, 2026.
• · TLGY merged with and into SPAC Merger Sub, with TLGY surviving as a wholly owned subsidiary of StablecoinX.
• · The Form 15 relies on Rule 12g-4(a)(1) and Rule 12h-3(b)(1)(i) to terminate/suspend the duty to file reports.
• · The deregistration does not affect StablecoinX's reporting obligations under the Exchange Act.

26-06-2026

Cboe BZX Exchange, Inc. has filed a Form 25-NSE with the SEC to delist the REX-Osprey ETH + Staking ETF (ESK) from the exchange, effective July 6, 2026. The delisting follows the redemption or maturity of the entire class of securities on June 22, 2026, and trading was suspended on June 12, 2026.

• · The delisting is effective at the opening of business on July 6, 2026.
• · The entire class of securities was redeemed or paid at maturity or retirement on June 22, 2026.
• · Trading of the security was suspended on June 12, 2026.
• · The filing is made under SEC Rule 17 CFR 240.12d2-2(a)(2).

26-06-2026

Ares Core Infrastructure Fund completed its modified Dutch auction tender offer to repurchase up to 5% of its outstanding shares (plus an additional 2% cushion as permitted by Rule 13e-4(f)(1)). On June 18, 2026, the offer expired with 199,367 shares validly tendered and not withdrawn; the Fund accepted 100% of those shares. The aggregate NAV of tendered shares was $4,970,126.10, and the Fund paid $4,912,299.50 in cash (after applicable early repurchase deductions) at $24.93 per share. The repurchase value was slightly below the original intent of up to 5% of outstanding shares, indicating modest shareholder participation relative to the total outstanding.

• · The Fund reserved the right to purchase an additional 2.0% of outstanding shares without amending or extending the offer.
• · Shares were repurchased at $24.93 per share (NAV as of May 31, 2026, less any early repurchase deduction).
• · Payment was made on or about June 26, 2026.
• · The repurchase amount of $4.91M is below the theoretical maximum if 5% of shares had been tendered, reflecting limited shareholder participation.

26-06-2026

Ares Strategic Income Fund announced the final results of its tender offer to repurchase up to 5% of its outstanding common shares as of April 30, 2026. The offer expired on June 18, 2026, with 56,891,917 shares validly tendered; the Fund accepted 19,767,079 shares on a pro rata basis (34.7% of tendered shares), paying an aggregate of $533,646,694 at $27.00 per share. The aggregate net asset value of all tendered shares was $1,536,081,746.

• · The tender offer was originally filed on May 20, 2026 and amended on June 25, 2026 before this Final Amendment.
• · The offer was oversubscribed: 56.9 million shares tendered vs. approximately 5% of outstanding shares targeted for repurchase.
• · The Fund applied 'odd lot' priority for holders of fewer than 100 Shares when accepting tenders on a pro rata basis.
• · The purchase price of $27.00 per share reflects the net asset value per share as of May 31, 2026 (the Valuation Date), less any applicable early repurchase deduction.
• · Payment was made on or about June 26, 2026.